Abstract
Trichodesma zeylanicum (Burm. f.) R. Br. was first published as Borago zeylanica Burm. f. by Burman (1768) from Australia, then transferred into genus Trichodesma to became Trichodesma zeylanicum (Burm. f.) R. Br. by Brown (1810). The purpose of this study was to assess the current state of research on the valuable medicinal plant Trichodesma Zeylanicum and to update existing knowledge. Trichodesma Zeylanicum, often known as Adhapushpi, is a member of the Boraginaceae family. It was traditionally used to treat a variety of diseases, including arthritis, fever, skin disease, arthralgia, and dysentery. Antioxidant, antiinflammatory, analgesic, antipyretic, antibacterial, and antidiabetic action has been documented for each portion of the plant. The pharmacognosy, phytochemistry, ethanopharmacology, and pharmacological properties of Trichodesma Zeylanicum are highlighted in this paper.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Research in Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
